ADVANBIO

AdvanBio is an innovative biotech company committed the advancement of medical laboratory technology, dedicated to serving human health... Our parent company is listed on Shanghai, Stock Exchange on September 1st, 2016, which is the first IVD manufacturer listed on the mainboard in Shanghai, China. We have 23 years of experience in Research and Development, $459 million operating income in 2020, and 5000+ employees worldwide. We highly value the importance of product R&D and technological innovation. The annual average R&D investment exceeds 10% in recent years. We apply strict research and development process management; focusing on the research and development of core raw materials, we have created a diagnostic antibody library for tens of thousands of antigen epitopes, with over 73% self-supply for antigen and antibody, which ensures the stability and safety of supply. We have become one of the leading companies with the most registered products and the most comprehensive product..

Also known as: AdvanBio Inc.

Primary location: Irvine United States